Some studies have suggested that severity of COVID-19 symptoms was negatively associated with circulating levels of BDNF, that is, patients with moderate to severe symptoms presented with lower circulating BDNF (22, 23) while recovery from COVID-19 infection was associated with increased levels of circulating BDNF (22). The gene discussed is BDNF; the disease is COVID-19.